 SAN JOSE, Calif., Nov. 22, 2019 PRNewswire -- Anixa Biosciences, Inc. ANIX, a biotechnology company focused on harnessing the bodys immune system in the fight against cancer, today announced a collaboration with Urology Centers of Alabama UCA in the CchekTM early prostate cancer detection study. UCA will provide patient samples in Anixas ongoing study, including support of clinical validation of Anixas CchekTM Prostate Cancer Confirmation test. 